πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9340522

Pyrazolone-derivatives and their use as PDE-4 inhibitors

TAKEDA GMBH Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9326946

Laminated tablet and manufacturing method therefor

Takeda Pharmaceutical Company Limited Β· Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9321757

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9320714

Tablet

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9315458

Nitrogen-containing heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9308249

Norovirus vaccine formulations

Takeda Vaccines, Inc. Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9309187

EP2 receptor agonists

TAKEDA GMBH Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9303045

5-HT3 receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9296746

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9290456

Pyridazinone compounds and their use as DAAO inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278938

Production method of imidazole derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278931

Cyclopropaneamine compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278096

Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity

Takeda Pharmaceuticals North America, Inc. Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9272028

Norovirus vaccine formulations

Takeda Vaccines, Inc. Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9265730

Stable solid preparations

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9260500

Peptide and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9255063

Colchicine solid-state forms; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9248119

Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inh

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9241910

Orally-disintegrating solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238029

Multiple PPI dosage form

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238639

Aromatic ring compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9233103

Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopi

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9226921

Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9221836

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted